MX2016006916A - Composicion farmaceutica, que comprende particulas de aglutinante de fosfato. - Google Patents
Composicion farmaceutica, que comprende particulas de aglutinante de fosfato.Info
- Publication number
- MX2016006916A MX2016006916A MX2016006916A MX2016006916A MX2016006916A MX 2016006916 A MX2016006916 A MX 2016006916A MX 2016006916 A MX2016006916 A MX 2016006916A MX 2016006916 A MX2016006916 A MX 2016006916A MX 2016006916 A MX2016006916 A MX 2016006916A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical composition
- phosphate binder
- includes particles
- particles
- certain
- Prior art date
Links
- 239000002245 particle Substances 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 4
- 239000002694 phosphate binding agent Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- FWZTTZUKDVJDCM-CEJAUHOTSA-M disodium;(2r,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol;iron(3+);oxygen(2-);hydroxide;trihydrate Chemical compound O.O.O.[OH-].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Na+].[Na+].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FWZTTZUKDVJDCM-CEJAUHOTSA-M 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229960004158 sucroferric oxyhydroxide Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a una composición farmacéutica, que comprende ciertas partículas de aglutinante de fosfato que tienen determinada distribución del tamaño de partículas, un procedimiento para la fabricación de la composición farmacéutica y el uso del oxihidróxido sucroférrico que tiene una determinada distribución del tamaño de partículas para la fabricación de una composición farmacéutica.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13194632 | 2013-11-27 | ||
| EP14156793 | 2014-02-26 | ||
| PCT/EP2014/075640 WO2015078900A1 (en) | 2013-11-27 | 2014-11-26 | Pharmaceutical composition, comprising phosphate binder particles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2016006916A true MX2016006916A (es) | 2016-08-17 |
| MX378141B MX378141B (es) | 2025-03-10 |
Family
ID=51987152
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016006916A MX378141B (es) | 2013-11-27 | 2014-11-26 | Composición farmacéutica, que comprende partículas de aglutinante de fosfato. |
Country Status (20)
| Country | Link |
|---|---|
| US (6) | US10624855B2 (es) |
| EP (3) | EP3073997B1 (es) |
| JP (5) | JP6431540B2 (es) |
| CN (1) | CN105764492B (es) |
| AU (3) | AU2014356500B2 (es) |
| CA (1) | CA2931173C (es) |
| CY (1) | CY1123956T1 (es) |
| DK (2) | DK3735962T3 (es) |
| ES (3) | ES2820737T3 (es) |
| FI (1) | FI3735962T3 (es) |
| HR (2) | HRP20201386T1 (es) |
| HU (2) | HUE066951T2 (es) |
| LT (2) | LT3073997T (es) |
| MX (1) | MX378141B (es) |
| PL (2) | PL3073997T3 (es) |
| PT (1) | PT3073997T (es) |
| RS (1) | RS60894B1 (es) |
| SI (2) | SI3735962T1 (es) |
| SM (1) | SMT202000461T1 (es) |
| WO (1) | WO2015078900A1 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI592159B (zh) | 2007-11-16 | 2017-07-21 | 威佛（國際）股份有限公司 | 藥學組成物 |
| US12171878B2 (en) | 2018-08-10 | 2024-12-24 | Kissei Pharmaceutical Co., Ltd. | Sucroferric oxyhydroxide-containing granules and pharmaceutical composition |
| CN109331036A (zh) * | 2018-10-17 | 2019-02-15 | 上海医药集团青岛国风药业股份有限公司 | 多糖铁在制备治疗高磷血症的药物中的应用 |
| CN109223824A (zh) * | 2018-11-23 | 2019-01-18 | 海南高升医药科技开发股份有限公司 | 一种治疗慢性肾病透析患者高磷血症的药物制备方法 |
| WO2020165781A1 (en) * | 2019-02-12 | 2020-08-20 | Biophore India Pharmaceuticals Pvt. Ltd | "improved process for the preparation of sucroferric oxyhydroxide" |
| CN110658102B (zh) * | 2019-10-30 | 2025-03-25 | 佛山市第一人民医院（中山大学附属佛山医院） | 一种脆碎仪 |
| CN112972407A (zh) * | 2019-12-18 | 2021-06-18 | 南京恒生制药有限公司 | 一种碳酸司维拉姆片剂组合物及其制备方法 |
| CA3163438A1 (en) | 2020-01-16 | 2021-07-22 | Vifor Fresenius Medical Care Renal Pharma, Ltd. | Particles of a mixture of iron(iii)-oxyhydroxide, sucrose and one or more starches, preferably of sucroferric oxyhydroxide |
| EP3932535A1 (en) | 2020-07-01 | 2022-01-05 | Vifor Fresenius Medical Care Renal Pharma, Ltd. | Manufacturing method for polynuclear iron compounds stabilized by carbohydrates and/or humic acid |
| CN116196330B (zh) * | 2023-03-16 | 2024-09-20 | 广东赛康制药厂有限公司 | 一种治疗高磷酸血症药物的制备工艺 |
| CN119950442B (zh) * | 2025-04-10 | 2025-08-05 | 华润双鹤药业股份有限公司 | 一种巯嘌呤微片及其制备方法和应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1249558A (en) | 1969-08-19 | 1971-10-13 | American Cyanamid Co | Process for the preparation of size-controlled colloidal iron sols and their stabilized solutions |
| DE4239442C2 (de) | 1992-11-24 | 2001-09-13 | Sebo Gmbh | Verwendung eines mit polynuklearen Metalloxidhydroxiden modifizierten Adsorptionsmaterials zur selektiven Elimination von anorganischem Phosphat aus proteinhaltigen Flüssigkeiten |
| DE19547356A1 (de) * | 1995-12-19 | 1997-06-26 | Vifor Int Ag | Adsorbens für Phosphat aus wäßrigem Medium, dessen Herstellung und Verwendung |
| US6117451A (en) | 1998-08-25 | 2000-09-12 | Pharmalogix, Inc. | Direct compression metformin hydrochloride tablets |
| US20020044969A1 (en) | 2000-05-22 | 2002-04-18 | Jerome Harden | Method for increasing the compressibility of poorly binding powder materials |
| US6358526B1 (en) | 2000-08-16 | 2002-03-19 | Rexall Sundown | Method of making tablets and tablet compositions produced therefrom |
| DE102004031181A1 (de) * | 2004-06-28 | 2006-01-19 | Vifor (International) Ag | Phosphatadsorbens |
| MY157620A (en) * | 2006-01-31 | 2016-06-30 | Cytochroma Dev Inc | A granular material of a solid water-soluble mixed metal compound capable of binding phosphate |
| US20080014541A1 (en) | 2006-05-08 | 2008-01-17 | Bob Sonntag | Fluidizing nozzle for high capacity particulate loaders |
| KR100734922B1 (ko) | 2006-11-22 | 2007-07-03 | (주)스마트코퍼레이션 | 접합용 전자유도가열기 |
| EP1932807A1 (en) * | 2006-12-14 | 2008-06-18 | Novartis AG | Inorganic compounds |
| ES2526171T3 (es) | 2006-12-14 | 2015-01-07 | Novartis Ag | Adsorbente de fosfato a base de hierro (III)-carbohidratos |
| DE102007031984A1 (de) | 2007-07-10 | 2009-01-15 | Forschungszentrum Karlsruhe Gmbh | Reaktor zur hochspannungsimpulstechnischen Desinfektion bakterienverseuchter Flüssigkeiten und Verfahren dazu |
| GB0720220D0 (en) * | 2007-10-16 | 2007-11-28 | Ineos Healthcare Ltd | Compound |
| TWI592159B (zh) * | 2007-11-16 | 2017-07-21 | 威佛（國際）股份有限公司 | 藥學組成物 |
| GB0814326D0 (en) * | 2008-08-05 | 2008-09-10 | Medical Res Council | Phosphate binding materials and their uses |
| GB0913525D0 (en) * | 2009-08-03 | 2009-09-16 | Ineos Healthcare Ltd | Method |
-
2014
- 2014-11-26 LT LTEP14803118.0T patent/LT3073997T/lt unknown
- 2014-11-26 ES ES14803118T patent/ES2820737T3/es active Active
- 2014-11-26 PL PL14803118T patent/PL3073997T3/pl unknown
- 2014-11-26 JP JP2016534625A patent/JP6431540B2/ja active Active
- 2014-11-26 PL PL20177472.6T patent/PL3735962T3/pl unknown
- 2014-11-26 HR HRP20201386TT patent/HRP20201386T1/hr unknown
- 2014-11-26 WO PCT/EP2014/075640 patent/WO2015078900A1/en not_active Ceased
- 2014-11-26 EP EP14803118.0A patent/EP3073997B1/en active Active
- 2014-11-26 SM SM20200461T patent/SMT202000461T1/it unknown
- 2014-11-26 HU HUE20177472A patent/HUE066951T2/hu unknown
- 2014-11-26 SI SI201432081T patent/SI3735962T1/sl unknown
- 2014-11-26 CA CA2931173A patent/CA2931173C/en active Active
- 2014-11-26 DK DK20177472.6T patent/DK3735962T3/da active
- 2014-11-26 ES ES20177472T patent/ES2980745T3/es active Active
- 2014-11-26 CN CN201480065206.0A patent/CN105764492B/zh active Active
- 2014-11-26 LT LTEP20177472.6T patent/LT3735962T/lt unknown
- 2014-11-26 US US15/039,633 patent/US10624855B2/en active Active
- 2014-11-26 FI FIEP20177472.6T patent/FI3735962T3/fi active
- 2014-11-26 DK DK14803118.0T patent/DK3073997T3/da active
- 2014-11-26 HU HUE14803118A patent/HUE051111T2/hu unknown
- 2014-11-26 PT PT148031180T patent/PT3073997T/pt unknown
- 2014-11-26 MX MX2016006916A patent/MX378141B/es unknown
- 2014-11-26 AU AU2014356500A patent/AU2014356500B2/en active Active
- 2014-11-26 HR HRP20240720TT patent/HRP20240720T1/hr unknown
- 2014-11-26 SI SI201431644T patent/SI3073997T1/sl unknown
- 2014-11-26 RS RS20201051A patent/RS60894B1/sr unknown
- 2014-11-26 ES ES20177467T patent/ES3006182T3/es active Active
- 2014-11-26 EP EP20177467.6A patent/EP3741360B1/en active Active
- 2014-11-26 EP EP20177472.6A patent/EP3735962B1/en active Active
-
2018
- 2018-05-16 JP JP2018094510A patent/JP6884124B2/ja active Active
-
2020
- 2020-03-16 US US16/820,177 patent/US11234937B2/en active Active
- 2020-03-16 US US16/820,190 patent/US11234938B2/en active Active
- 2020-08-12 AU AU2020217386A patent/AU2020217386B2/en active Active
- 2020-09-03 CY CY20201100828T patent/CY1123956T1/el unknown
-
2021
- 2021-05-11 JP JP2021080281A patent/JP7335291B2/ja active Active
- 2021-12-16 US US17/644,599 patent/US11446251B2/en active Active
- 2021-12-16 US US17/644,612 patent/US11446252B2/en active Active
-
2022
- 2022-06-22 AU AU2022204380A patent/AU2022204380B2/en active Active
- 2022-08-18 US US17/820,781 patent/US20220387327A1/en not_active Abandoned
-
2023
- 2023-08-17 JP JP2023132809A patent/JP7652844B2/ja active Active
-
2025
- 2025-03-14 JP JP2025040849A patent/JP2025106280A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2016006916A (es) | Composicion farmaceutica, que comprende particulas de aglutinante de fosfato. | |
| CL2016002772A1 (es) | Composiciones de insulina de rápida acción | |
| MX2015013247A (es) | Formulacion de acetato de abiraterona. | |
| CL2015002891A1 (es) | Deaza-purinonas macrocíclicas para el tratamiento de infecciones virales. | |
| BR112015021521A2 (pt) | anticorpos anti-crth2 e métodos para seu uso | |
| UY35025A (es) | Composición de lechada de cal de gran finura | |
| MX2015016627A (es) | Vacuna para la malaria. | |
| BR112015023523B8 (pt) | Composições farmacêuticas e recipiente de forma de dosagem única | |
| EA031255B8 (ru) | Состав с отсроченным высвобождением, содержащий гранулы цистеамина, и способы его получения и применения | |
| IN2013MU03641A (es) | ||
| UY36292A (es) | Compuestos de tetrahidroquinolina para su uso como inhibidores de bromodominios | |
| EP2964032A4 (en) | COMPOSITIONS AND METHOD FOR THE PRODUCTION OF VIRUSELIC PARTICLES | |
| CR20140530A (es) | Metodos para producir clorhidrato de anamorelina que tiene contenido controlado de cloruro | |
| EA201600412A1 (ru) | Способ производства неорганического материала в виде частиц | |
| MX2015016603A (es) | Composiciones de corticosteroides. | |
| MX382918B (es) | Proceso para fabricar partículas de resinato de fenilefrina; partículas de resinato de fenilefrina y uso de las partículas de resinato de fenilefrina en formulaciones farmacéuticas. | |
| MX2015015899A (es) | Metodos para producir particulas que comprenden proteinas terapeuticas. | |
| MX365591B (es) | Formulacion de metaxalona. | |
| PH12015502029A1 (en) | Phenylephrine resinate particles and use thereof in pharmaceutical formulations | |
| CL2015001921A1 (es) | Formulaciones de lorazepam de liberación controlada | |
| PH12015502015A1 (en) | Coated phenylephrine particles and use thereof in pharmaceutical formulations | |
| PT3735962T (pt) | Composição farmacêutica que compreende partículas de quelante de fosfato | |
| IN2013CH00453A (es) | ||
| IN2013CH05769A (es) |